To overcome the “stealth” characteristics of anionic liposomes, we enhanced the tumor-targeting ability of RRIALP-C4 through the surface charge modification and RGD targeting based on the investigation that charge modification would greatly enhance RRIALP-C4 entry into A549 cells. The gene discussed is C4A; the disease is neoplasm.